Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA

Journal of Clinical Virology

Volumn 45, Issue 2, 2009, Pages 125-128

  Ludolfs, Diana ^a   Reinholz, Michael ^a   Schmitz, Herbert ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Domain III; Immune complex ELISA; Serotype specific antibodies; TBE virus

Indexed keywords

IMMUNOGLOBULIN G; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ANTIGEN ED 3; YELLOW FEVER VACCINE;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; LASSA VIRUS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VIRUS NEUTRALIZATION; WEST NILE FLAVIVIRUS;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, VIRAL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 67349099629     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.03.016     Document Type: Article

References (37)

1. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11 (2005) 522-530
2. Nybakken G.E., Oliphant T., Johnson S., Burke S., Diamond M.S., and Fremont D.H. Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437 (2005) 764-769
3. Throsby M., Geuijen C., Goudsmit J., Bakker A.Q., Korimbocus J., Kramer R.A., et al. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J Virol 80 (2006) 6982-6992
4. Ludolfs D., Niedrig M., Paweska J.T., and Schmitz H. Reverse ELISA for the detection of anti West Nile virus IgG antibodies in humans. Eur J Clin Microbiol Infect Dis. 26 (2007) 467-473
5. Emmerich P., Gunther S., and Schmitz H. Strain-specific antibody response to Lassa virus in the local population of west Africa. J Clin Virol 42 (2008) 40-44
6. Gritsun T.S., Lashkevich V.A., and Gould E.A. Tick-borne encephalitis. Antiviral Res 57 (2003) 129-146
7. Holbrook M.R., Shope R.E., and Barrett A.D. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. J Clin Microbiol 42 (2004) 4101-4110
8. Donoso Mantke O., Schadler R., and Niedrig M. A survey on cases of tick-borne encephalitis in European countries. Euro Surveill 13 17 (2008)
9. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 21 Suppl. 1 (2003) S36-40
10. Niedrig M., Vaisviliene D., Teichmann A., Klockmann U., and Biel S.S. Comparison of six different commercial IgG-ELISA kits for the detection of TBEV-antibodies. J Clin Virol 20 (2001) 179-182
11. Zenz W., Pans iH., Zoehrer B., Mutz I., Holzmann H., Kraigher A., et al. Tick-borne encephalitis in children in Styria and Slovenia between 1980 and 2003. Pediatric Infect Dis J 24 (2005) 892-896
12. Niedrig M., Avsic T., Aberle S.W., Ferenczi E., Labuda M., Rozentale B., et al. Quality control assessment for the serological diagnosis of tick borne encephalitis virus infections. J Clin Virol 38 (2007) 260-264
13. Heinz F.X., Berger R., Tuma W., and Kunz C. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition. Virology 130 (1983) 485-501
14. Mandl C.W., Guirakhoo F., Holzmann H., Heinz F.X., and Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol 63 (1989) 564-571
15. Fonseca B.A., Khoshnood K., Shope R.E., and Mason P.W. Flavivirus type-specific antigens produced from fusions of a portion of the E protein gene with the Escherichia coli trpE gene. Am J Trop Med Hyg 44 (1991) 500-508
16. Holzmann H., Mandl C.W., Guirakhoo F., Heinz F.X., and Kunz C. Characterization of antigenic variants of tick-borne encephalitis virus selected with neutralizing monoclonal antibodies. J Gen Virol 70 (1989) 219-222
17. Gromowski G.D., and Barrett A.D. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366 (2007) 349-360
18. Mota J., Acosta M., Argotte R., Figueroa R., Mendez A., and Ramos C. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein. Vaccine 23 (2005) 3469-3476
19. Chen S., Yu M., Jiang T., Deng Y., Qin C., and Qin E. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein. DNA Cell Biol 26 (2007) 361-367
20. Lazo L., Zulueta A., Hermida L., Blanco A., Sanchez J., Valdes I., et al. The Dengue-4 envelope domain III fused twice within the meningococcal P64k protein carrier induces partial protection in mice. Biotechnol Appl Biochem 52 (2008) 265-271
21. Etemad B., Batra G., Raut R., Dahiya S., Khanam S., Swaminathan S., et al. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. Am J Trop Med Hyg 79 (2008) 353-363
22. Martina B.E., Koraka P., van den Doel P., van Amerongen G., and Rimmelzwaan G.F. OAD. Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 26 (2008) 153-157
23. Beasley D.W., Holbrook M.R., Travassos Da Rosa A.P., Coffey L., Carrara A.S., Phillippi-Falkenstein K., et al. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J Clin Microbiol 42 (2004) 2759-2765
24. Izquierdo A., Bernardo L., Martin J., Santana E., Hermida L., Guillen G., et al. Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus. Virus Res 138 (2008) 135-138
25. Ludolfs D., Schilling S., Altenschmidt J., and Schmitz H. Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens. J Clin Microbiol 40 (2002) 4317-4320
26. Sukupolvi-Petty S., Austin S.K., Purtha W.E., Oliphant T., Nybakken G.E., Schlesinger J.J., et al. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 81 (2007) 12816-12826
27. Aoki S., Li J., Itagaki S., Okech B.A., Egwang T.G., Matsuoka H., et al. Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth. J Biol Chem 277 (2002) 47533-47540
28. Sachers M., Emmerich P., Mohr H., and Schmitz H. Simple detection of antibodies to different viruses using rheumatoid factor and enzyme-labelled antigen (ELA). J Virol Methods 10 (1985) 99-110
29. Dobler G., Treib J., Kiessig S.T., Blohn W.V., Frosner G., and Haass A. Diagnosis of tick-borne encephalitis: evaluation of sera with borderline titers with the TBE-ELISA. Infection 24 (1996) 405-406
30. Simmons M., Porter K.R., Escamilla J., Graham R., Watts D.M., Eckels K.H., et al. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies. Am J Trop Med Hyg 58 (1998) 144-151
31. Crill W.D., and Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75 (2001) 7769-7773
32. Oliphant T., Nybakken G.E., Engle M., Xu Q., Nelson C.A., Sukupolvi-Petty S., et al. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol 80 (2006) 12149-12159
33. Lai C.Y., Tsai W.Y., Lin S.R., Kao C.L., Hu H.P., King C.C., et al. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82 (2008) 6631-6643
34. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 (2003) 550-555
35. Yoshii K., Hayasaka D., Goto A., Obara M., Araki K., Yoshimatsu K., et al. Enzyme-linked immunosorbent assay using recombinant antigens expressed in mammalian cells for serodiagnosis of tick-borne encephalitis. J Virol Methods 108 (2003) 171-179
36. Obara M., Yoshii K., Kawata T., Hayasaka D., Goto A., Mizutani T., et al. Development of an enzyme-linked immunosorbent assay for serological diagnosis of tick-borne encephalitis using subviral particles. J Virol Methods 134 (2006) 55-60
37. Roberson J.A., Crill W.D., and Chang G.J. Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol 45 (2007) 3167-3174